Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-26-000138

EVP, Chief Commercial Officer sold 2,633 shares at $498.42 ($1,312,340)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

McKechnie Duncan · EVP, Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-11 Sale : show line 1 in the form 10b5-1 −2,633 $498.42 $1,312,340 12,489 D
Open-market sales · 2,633 sh · avg $498.42 · $1,312,340
Loading xslF345X05/wk-form4_1773432707.xml…